Azure Biotech Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$3.05M
Azure Biotech General Information
Description
Developer of a drug designed to address the unmet health needs of postmenopausal women. The company's services are dedicated to developing a unique, local, easily administered, non-estrogen product, especially attractive to breast cancer survivors, enabling women to courageously transition through life's natural cycles.
Contact Information
Website
www.azurebiotech.comCorporate Office
- 500 East 85th Street
- 19D
- New York, NY 10028
- United States
Corporate Office
- 500 East 85th Street
- 19D
- New York, NY 10028
- United States
Azure Biotech Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Seed Round | 06-May-2022 | $3.05M | Completed | Generating Revenue | ||
1. Angel (individual) | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Azure Biotech Comparisons
Industry
Financing
Details
Azure Biotech Competitors (4)
One of Azure Biotech’s 4 competitors is Celmatix, a Venture Capital-Backed company based in New York, NY.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Celmatix | Venture Capital-Backed | New York, NY | ||||
ObsEva | Formerly VC-backed | Geneva, Switzerland | ||||
Evofem Biosciences | Formerly VC-backed | San Diego, CA | ||||
Agile Therapeutics | Formerly VC-backed | Princeton, NJ |
Azure Biotech Patents
Azure Biotech Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
JP-7168557-B2 | Vaginal delivery system containing selective estrogen receptor modulators (serms) and uses thereof | Active | 20-May-2016 | ||
EP-3458015-A1 | Vaginal delivery systems containing selective estrogen receptor modulator (serm) and uses thereof | Pending | 20-May-2016 | ||
US-10857127-B2 | Vaginal delivery systems containing selective estrogen receptor modulator (serm) and uses thereof | Active | 20-May-2016 | ||
US-20170333394-A1 | Vaginal delivery systems containing selective estrogen receptor modulator (serm) and uses thereof | Active | 20-May-2016 | ||
JP-2019519602-A | Vaginal delivery system containing a selective estrogen receptor modulator (serm) and use thereof | Active | 20-May-2016 | A61K31/40 |
Azure Biotech Signals
Azure Biotech FAQs
-
When was Azure Biotech founded?
Azure Biotech was founded in 2013.
-
Where is Azure Biotech headquartered?
Azure Biotech is headquartered in New York, NY.
-
What is the size of Azure Biotech?
Azure Biotech has 5 total employees.
-
What industry is Azure Biotech in?
Azure Biotech’s primary industry is Biotechnology.
-
Is Azure Biotech a private or public company?
Azure Biotech is a Private company.
-
What is Azure Biotech’s current revenue?
The current revenue for Azure Biotech is
. -
How much funding has Azure Biotech raised over time?
Azure Biotech has raised $3.05M.
-
Who are Azure Biotech’s competitors?
Celmatix, ObsEva, Evofem Biosciences, and Agile Therapeutics are competitors of Azure Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »